Weight loss & management clinic

Achieve sustainable, long-term weight reduction with individualised clinical guidance from our accredited pharmacy team. We offer access to the latest medically proven weight management treatments, including dual GIP/GLP-1 receptor agonist weekly injections (Mounjaro / tirzepatide), GLP-1 weekly injections (Wegovy / semaglutide), daily injections (Saxenda / liraglutide), and oral treatment options such as Wegovy tablets, Foundayo tablets, Mysimba (naltrexone/bupropion), and Orlistat (Xenical). Your journey includes baseline health measurements, BMI evaluation, ongoing dose titration, and continuous lifestyle coaching.

Proven medications Pharmacist supervised Ongoing check-ins

About this service

Clinical evaluation

We assess your BMI, medical history, current medicines, and personal lifestyle factors in a private consultation room.

Latest medical therapies

Access modern injectable pens and oral tablets that reduce appetite, curb cravings, and enhance satiety.

Dedicated support & titration

Step-by-step guidance on self-administration, side effect management, and dose escalation to ensure safe, lasting results.

How it works

Private consultation

Discuss your weight loss history, lifestyle habits, and medical background privately with our pharmacist.

Health screening & eligibility

We measure your height, weight, BMI, and blood pressure to ensure safe medical eligibility according to clinical guidelines.

Treatment selection & training

If eligible, we prescribe and supply your chosen medication and demonstrate how to use your injectable pen or oral tablets correctly.

Ongoing monitoring

Regular monthly check-ins to monitor weight progress, review tolerance, and safely titrate your dosage.

Questions about this service

Who is clinically eligible for medical weight loss treatments?

Medical weight loss therapies are generally indicated for adults with a BMI of 30 or higher (classified as obese), or adults with a BMI of 27 or higher who have weight-related health conditions (such as high blood pressure, high cholesterol, pre-diabetes, or sleep apnoea). Our pharmacist will assess your clinical suitability during your consultation.

What is the difference between Mounjaro, Wegovy, and Saxenda?

Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist injected once weekly. Wegovy (semaglutide) is a GLP-1 receptor agonist injected once weekly. Saxenda (liraglutide) is a daily GLP-1 injection. All work by mimicking natural gut hormones to regulate appetite, delay gastric emptying, and promote fullness. Our pharmacist will discuss which option best aligns with your goals and health profile.

Are oral tablet alternatives available if I prefer not to inject?

Yes. For patients who prefer oral medications, we offer Wegovy oral tablets, Foundayo tablets, Mysimba (a combination of naltrexone and bupropion that targets the brain hunger and reward pathways), and Orlistat (which prevents the absorption of approximately one-third of dietary fat).

How quickly will I see results?

Patients typically start noticing a reduction in appetite within the first few days of starting treatment. Clinical studies show significant and sustained weight reduction over several months when medication is paired with balanced nutrition and regular physical activity.

Is this a private service and what are the costs?

This is a private clinical service. Pricing covers your clinical assessment, the medication, injecting supplies/needles if applicable, and all continuous follow-up support. We maintain complete transparent pricing with no hidden fees.